Indisetron Kyorin

IDrugs

Volumn 5, Issue 3, 2002, Pages 278-280

  Mulè, Flavia ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLSEROTONIN; 3 (5 METHYL 1H IMIDAZOL 4 YL) 1 (1 METHYL 1H INDOL 3 YL) 1 PROPANONE; ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; AZASETRON; CISPLATIN; COPPER SULFATE; CYCLOPHOSPHAMIDE; DOLASETRON MESILATE; GRANISETRON; INDISETRON; IRINOTECAN; NEUROKININ 1 RECEPTOR ANTAGONIST; ONDANSETRON; SEROTONIN; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN 4 ANTAGONIST; SEROTONIN 4 RECEPTOR; TRITIUM; UNCLASSIFIED DRUG;

CANCER; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; DISEASE SEVERITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG EFFECT; DRUG INDICATION; DRUG METABOLISM; DRUG POTENCY; DRUG SCREENING; GASTROINTESTINAL SYMPTOM; HEADACHE; HOT FLUSH; HUMAN; NONHUMAN; PR INTERVAL; QRS COMPLEX; QT INTERVAL; REVIEW; SIDE EFFECT; VERTIGO; VOMITING;

EID: 0141560768     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. 3 anatagonist, N-3389, on increased abdominal afferent vagal nerve activities induced by emetic drugs in ferrets. Endo T, Nemoto M, Minami M, Togashi M, Monma Y, Yoshioka M, Saito H, Hagihara K Jpn J Pharmacol 1994 64 Suppl 1 Abs 0245
2. 4 receptor antagonist.
3. 197417 N-3389. Rabasseda X, Mealy N, Castaner J Drugs Future 1995 20 8 780-783 Report on the synthetic pathway to and pharmacological actions of indisertion.
4. 230435 Role of serotonin in emesis. Minami M, Endo T, Hirafuji M Folia Pharmacol Jpn 1966 108 5 233-242
5. 245338 Clinical and pharmacokinetic study of oral NK611, a new podophyllotoxin derivative. Pagani O, Zucchetti M, Sessa C, De Jong J, D'Incalci M, De Fusco M, Kaeser-Frohlich A, Hanauske A, Cavalli F Cancer Chemother Pharmacol 1996 38 6 541-547
6. 4 receptor antagonist, in ferrets. Minami M, Endo T, Tamakai H, Ogawa T, Hamaue N, Hirafuji M, Monma Y, Yoshioka M, Hagihara K Eur J Pharmacol 1997 321 3 333-342 Study demostrating the anti-emetic effects of N-3389 in ferrets.
7. 4 receptor modulation of tachykinergic excitation of rat oesophageal tunica muscularis mucosae. Goldhill J, Porquet MF, Angel I Eur J Pharmacol 1997 323 2-3 229-233
8. 4 receptor antagonists.
9. 255779 Pharmacokinetics and safety of single intravenous and oral doses of dolasetron mesylate in healthy women. Keung ACF, Landriault H, Lefebvre M, Gossard D, Dempsey EE, Juneau M, Dimmitt D, Castles M, Roberts L, Spenard J Biopharm Drug Dispos 1997 18 4 361-369
10. 354381 N-3389. Indisetron hydrochloride. Drugs Future 1997 22 8 914
11. 3 receptor antagonist on cisplatin-induced emesis in the ferret. Monma Y, Endo T, Minami M, Hagihara K, Tadokoro T, Suzuki Y Jpn J Pharmacol 1992 59 Suppl 1 261P
12. 3 receptor antagonist. Hayakawa T, Hagihara K, Arai T, Mino S, Tadokoro T, Tanaka Y Jpn J Pharmacol 1992 59 Suppl 1 259P
13. 356568 Drug development pipeline: Indisetron. Kyorin Pharmaceutical Co Ltd Company Communication 2000 February 18
14. 433021 Neurochemistry and neuropharmacology of emesis - The role of serotonin. Endo T, Minami M, Hirafuji M, Ogawa T, Akita K, Nemoto M, Saito H, Yoshioka M, Parvez SH Toxicology 2000 153 189-201 Review of the role of serotonin in emesis.